EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹971 Cr | ₹727 Cr | ₹747 Cr | ₹973 Cr | ₹657 Cr |
What is the latest Profit Before Tax of EMCURE PHARMACEUTICALS ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹971 Cr |
| Mar2024 | ₹727 Cr |
| Mar2023 | ₹747 Cr |
| Mar2022 | ₹973 Cr |
| Mar2021 | ₹657 Cr |
How is Profit Before Tax of EMCURE PHARMACEUTICALS Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹971 Cr | 33.57 | |
| Mar2024 | ₹727 Cr | -2.67 | |
| Mar2023 | ₹747 Cr | -23.17 | |
| Mar2022 | ₹973 Cr | 47.95 | |
| Mar2021 | ₹657 Cr | - | |
Compare Profit Before Tax of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹29,107.4 Cr | 4.9% | 5.3% | 21.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 4.9% |
5.3% |
21.4% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses